Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised Trial of Chlorambucil Versus Fludarabine as Initial Therapy of Waldenström's Macroglobulinaemia and Splenic Lymphoma With Villous Lymphocytes

NCT00608374 is registered in ClinicalTrials.gov with Taunton and Somerset Hospital as lead sponsor.

NCT NCT00608374
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00608374 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised Trial of Chlorambucil Versus Fludarabine as Initial Therapy of Waldenström's Macroglobulinaemia and Splenic Lymphoma With Villous Lymphocytes
Lead sponsor
Taunton and Somerset Hospital
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2006
Completion date
January 31, 2013
Enrollment
400 (estimated)
Sites
49

Conditions

As the registry lists them; a condition with its own page is linked.

lymphoma